AZTA Key Statistics, Chart & Performance
The current stock price of AZTA is 35.56 USD. In the past month the price increased by 18.93%. In the past year, price decreased by -23.05%.
AZTA Latest News, Press Relases and Analysis
AZTA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.38 | 221.98B | ||
| DHR | DANAHER CORP | 29.41 | 160.19B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 186.73 | 56.74B | ||
| A | AGILENT TECHNOLOGIES INC | 27.51 | 43.52B | ||
| IQV | IQVIA HOLDINGS INC | 19.78 | 39.17B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.29 | 30.17B | ||
| WAT | WATERS CORP | 31.77 | 24.02B | ||
| ILMN | ILLUMINA INC | 30.15 | 20.09B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.21 | 19.95B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.43 | 16.69B | ||
| TEM | TEMPUS AI INC | N/A | 13.86B | ||
| RVTY | REVVITY INC | 21.8 | 11.84B |
Related stock screener links
About AZTA
Company Profile
Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Company Info
AZENTA INC
200 Summit Drive, 6Th Floor
Burlington MASSACHUSETTS US
Employees: 3000
Phone: 19782622400
AZENTA INC / AZTA FAQ
Can you describe the business of AZENTA INC?
Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Can you provide the latest stock price for AZENTA INC?
The current stock price of AZTA is 35.56 USD. The price decreased by -1.96% in the last trading session.
Does AZENTA INC pay dividends?
AZTA does not pay a dividend.
What is the ChartMill technical and fundamental rating of AZTA stock?
AZTA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the market expecting AZTA stock to perform?
14 analysts have analysed AZTA and the average price target is 33.95 USD. This implies a price decrease of -4.52% is expected in the next year compared to the current price of 35.56.
What is the employee count for AZTA stock?
AZENTA INC (AZTA) currently has 3000 employees.
What is the next earnings date for AZTA stock?
AZENTA INC (AZTA) will report earnings on 2026-02-03, after the market close.
AZTA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to AZTA. When comparing the yearly performance of all stocks, AZTA is a bad performer in the overall market: 64.76% of all stocks are doing better.
AZTA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AZTA. While AZTA has a great health rating, there are worries on its profitability.
AZTA Financial Highlights
Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.53. The EPS increased by 29.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.53% | ||
| ROE | -6.67% | ||
| Debt/Equity | 0 |
AZTA Forecast & Estimates
14 analysts have analysed AZTA and the average price target is 33.95 USD. This implies a price decrease of -4.52% is expected in the next year compared to the current price of 35.56.
For the next year, analysts expect an EPS growth of 48.94% and a revenue growth 4.15% for AZTA